Numerous cancer cells depend on glutamine, unless they express GS, making Alanine-serine-cysteine (ASC) amino acid transporter 2 (ASCT2; SLC1A5) a potential target for cancer chemotherapy [67]. Here, SLC1A5 is linked to cancer.